Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6629 record(s)

Req # A-2021-001159

Adverse Drug Reaction (ADR) for LEFLUNOMIDE. Report number: E2B_04084876.

Organization: Health Canada

781 page(s)
January 2025

Req # A-2021-001278

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-112897-341.

Organization: Health Canada

13 page(s)
January 2025

Req # A-2021-001720

Adverse Drug Reaction (ADR) for IRBESARTAN. Report number: E2B_04570755.

Organization: Health Canada

17 page(s)
January 2025

Req # A-2021-001790

Adverse Drug Reactions (ADRs) for . Report numbers: 000961243, E2B_04328196, E2B_04357361, 000961470, 000966672, E2B_04441408, 000959870, E2B_04467091, E2B_04478619, E2B_04562129, 000958454.

Organization: Health Canada

214 page(s)
January 2025

Req # A-2022-000069

Adverse Drug Reactions (ADRs). Report numbers: E2B_03366429, E2B_03375530.

Organization: Health Canada

43 page(s)
January 2025

Req # A-2022-000285

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100922-261.

Organization: Health Canada

36 page(s)
January 2025

Req # A-2022-000472

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-105563-5, Deputy Ministerial Meeting with the Standards Council of Canada.

Organization: Health Canada

5 page(s)
January 2025

Req # A-2022-000613

Adverse Drug Reactions (ADRs). Report numbers: E2B_03568120, E2B_05372839, 000993462, E2B_05378319, E2B_05377509, E2B_01968076, E2B_05375191, E2B_05338396, E2B_05367439, E2B_05390678.

Organization: Health Canada

167 page(s)
January 2025

Req # A-2022-000682

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-106142-617, Deputy Ministerial Meeting with the Canadian Agency for Drugs and Technologies in Health.

Organization: Health Canada

49 page(s)
January 2025

Req # A-2022-000761

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-108147-896.

Organization: Health Canada

13 page(s)
January 2025
Date modified: